Illumina Plans International Manufacturing Hub as it Expands San Diego Facilities | GenomeWeb
Illumina is looking to establish an international manufacturing facility with the goal of manufacturing its BeadChips for gene expression and genotyping at a "high level" some time next year, according to the firm's CEO.
 
Jay Flatley told investors during a first-quarter earnings call two weeks ago that while the company is in the midst of a large-scale build-out at its San Diego manufacturing facilities, it now is committed to transferring some of its manufacturing off shore.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

CBC Marketplace commissions DNA testing of chicken sandwiches at Subway and other fast-food chains.

In a speech to Congress, President Donald Trump called the drug approval process at FDA "slow and burdensome."

In Genome Research this week: algorithm to tease out strains from metagenomic sequences, drug resistance mechanisms in cancer cells, and more.

Variants in the IFITM3 gene affect inflammatory response to infection, UPI reports.